Rating: HOLD
| Metric | Value |
|---|---|
| Current Price | $121 |
| Triangulated Fair Value | $102 |
| 12-mo Scenario PWEV | $119 |
| Implied Return | -16% |
| Forward P/E | 15.3x |
| Market Cap | $27B |
| 52-Week Range | $92 – $132 |
Methodology: Valuation triangulated across five independent anchors — Monte Carlo (Student-t + regime switching), an independent DCF, peer re-rating, a sum-of-parts, and a scenario-weighted PWEV. Figures reconciled to Alpha Vantage 2026-06-26. Each chart below sits with the part of the thesis it evidences.
Investment Thesis
The bull case — 'Bull — Cycle + Re-Rate' (8% weight) — targets $211, +74% vs spot. It needs Gross Margin to surprise to the upside.
The dashboard below is the whole argument on one page: spot ($121) against each valuation anchor, the scenario tree, technicals and the options-implied move.
Anti-Thesis (The Real Bear Case)
The structural case — 'Structural — Brand / Volume Erosion' (20%) — targets $51, -58% vs spot. This sits below the 52-week low — a genuine structural impairment, not a mild pullback.
Key Debate
Gross Margin explains 56% of Monte Carlo outcome variance — the single variable that decides which side is right.
Earnings-Call Disconfirmation & Sentiment
Derived signals from the MCH market-data store (Alpha Vantage transcripts + news). Quantitative tone only — a disconfirmation flag, not a substitute for reading the call.
Management vs analyst tone (2026Q1): management +0.52 vs analyst floor +0.00 → delta +0.52 (n=27 mgmt / 16 Q&A; 77th pctile across the S&P book, z +0.8).
Flag: TYPICAL — management-vs-analyst tone within the normal cross-sectional range.
| Quarter | Mgmt | Analyst | Delta |
|---|---|---|---|
| 2026Q1 | +0.52 | +0.00 | +0.52 |
| 2025Q4 | +0.30 | +0.16 | +0.14 |
| 2025Q3 | +0.27 | +0.05 | +0.22 |
| 2025Q2 | +0.42 | +0.35 | +0.06 |
News (last 365d, 1000 articles): avg ticker sentiment +0.19 (bullish 26% / bearish 3%)
Scenario Analysis
The tree runs from a structural 'Structural — Brand / Volume Erosion' downside ($51) to a 'Bull — Cycle + Re-Rate' bull case ($211); the probability-weighted blend (PWEV $119) is -2% versus spot.
| Scenario | Probability | Target | Return |
|---|---|---|---|
| Structural — Brand / Volume Erosion | 20% | $51 | -58% |
| Downturn — Construction / Industrial Slump | 18% | $89 | -27% |
| Base — Pricing-Led Compounding | 33% | $123 | +2% |
| Growth — Share Gains + Mix | 21% | $167 | +37% |
| Bull — Cycle + Re-Rate | 8% | $211 | +74% |
| Probability-Weighted (PWEV) | — | $119 | -2% |
Scenario rationale — what each probability buys (the driver path behind every target):
- Structural — Brand / Volume Erosion (20%, $51). Structural impairment — raw-material squeeze / volume loss: earnings AND the multiple compress together. Target sits below the 52-week low by construction. Drivers — implied_target: 50.97; probability: 0.2.
- Downturn — Construction / Industrial Slump (18%, $89). Cyclical downturn — coatings/specialty volumes + raw-material spread + pricing power weakens for 1–2 years before normalising. Drivers — implied_target: 88.91; probability: 0.18.
- Base — Pricing-Led Compounding (33%, $123). Mid-cycle — normalised coatings/specialty volumes + raw-material spread + pricing power; disciplined capital allocation; steady returns. Drivers — implied_target: 123.49; probability: 0.33.
- Growth — Share Gains + Mix (21%, $167). Upside — share gains + input deflation lifts earnings above mid-cycle; the multiple expands modestly. Drivers — implied_target: 166.71; probability: 0.21.
- Bull — Cycle + Re-Rate (8%, $211). Upside tail — sustained tight conditions or a structural re-rate on share gains + input deflation. Drivers — implied_target: 210.55; probability: 0.08.
Valuation Triangulation
Five anchors — but read them with their basis in mind. The Monte Carlo, the DCF terminal, and the peer re-rate all key off a market multiple, so they are not fully independent; only the discounted cash flows themselves are genuinely multiple-free. The discipline is to read the spread and weight the cash-based view, not to treat five numbers as five independent votes.
| Method | Basis | Fair Value | vs Spot |
|---|---|---|---|
| Monte Carlo median (Student-t + regime) | multiple | $105 | -13% |
| Peer P/E re-rate | multiple | $191 | +57% |
| Peer EV/Revenue re-rate | multiple | $229 | +89% |
| Scenario PWEV | multiple | $119 | -2% |
| DCF (5-year + terminal) | cash flow + terminal × | $90 | -26% |
| Triangulated (weighted) | — | $102 | -16% |
peer P/E re-rate excluded from the weighted blend — diverges >55% from the Monte-Carlo / scenario core. For a high-leverage equity the per-share DCF (enterprise value less large net debt) is hypersensitive to the terminal multiple; a peer re-rate across heterogeneous margins is apples-to-oranges. Shown above for reference; the blend leans on the multiple-discipline and scenario anchors.
Rating vs blend — the key debate. The rating tracks the multiple-discipline fair value (Monte Carlo $105 + scenario PWEV $119, ≈ spot); the weighted blend $102 (-16%) sits below it because the cash-flow DCF ($90) is materially more conservative than the market multiple. Whether the current multiple is justified is the central question for this name — and the principal downside risk to the rating.
Monte Carlo — the distribution, not a point
10,000 paths, Student-t shocks (fat tails) with a regime-switching overlay. The median lands at $105 and 39% of paths finish above spot. The variance decomposition shows the gross margin is the dominant swing factor (56% of variance). The fundamental driver, not the multiple, sets the spread — a cleaner setup.
DCF — the cash-flow anchor
Independent of the market multiple: a 5-year path, WACC 8.5%, 13x terminal FCF multiple → $90. This anchor is deliberately the heaviest (41%): it is the valuation least hostage to the current multiple regime.
Peer benchmarking — relative value
Against the peer cohort, re-rating to the peer-median forward multiple (P/E 24.08x) implies $191. A premium is only justified by superior growth/margins; otherwise it is multiple risk. Weighted just 12% so the market's mood does not drive the fair value.
Across all anchors the spread is wide (genuine disagreement — low valuation confidence).
Revenue-Segment Breakdown
The company-specific drivers behind the valuation — each segment carries its own growth, margin, multiple and capex intensity. (Tags: FACT reported · ESTIMATE from disclosures · INFERENCE judgment.)
| Segment | Revenue | Mix | Growth | Op margin | Multiple | Capex % | Tag |
|---|---|---|---|---|---|---|---|
| Specialty Chemicals / Coatings | $16.1B | 100% | 5% | 14% | 15x | 4% | ESTIMATE |
Named Exposures
Demand & pricing cycle (FACT/ESTIMATE)
| Dimension | Assessment |
|---|---|
| driver | coatings/specialty volumes + raw-material spread + pricing power |
| net_debt_or_cash_b | -6.16 |
Capital intensity & shareholder returns (ESTIMATE)
| Dimension | Assessment |
|---|---|
| capex_pct_revenue | 0.04 |
| div_yield | 0.0232 |
Structural risk vs optionality (INFERENCE)
| Dimension | Assessment |
|---|---|
| downside | raw-material squeeze / volume loss |
| upside | share gains + input deflation |
Industry Context — Materials — Quality
This name sits in the Materials — Quality as a coatings. coatings/specialty volumes + raw-material spread + pricing power Its scenarios are not guessed in isolation — they inherit a single, shared view of the cluster's driver cycle, so the names that depend on the same event are mutually consistent.
Value chain: LIN (gases) · SHW (coatings) · ECL (coatings) · APD (gases) · CTVA (ag_specialty) · PPG (coatings) · IFF (coatings) · DD (coatings)
| Shared state | Capex path | House view | This name implies |
|---|---|---|---|
| Industrial Recession — Demand / De-Rate | 38% | 38% | |
| Mid-Cycle — Steady Compounding | 33% | 33% | |
| Expansion — Volume + Pricing Upside | 29% | 29% |
On the cluster's key downside — Industrial Recession — Demand / De-Rate () — this name implies 38% vs the cluster house view of 38% (in line with the house). The cluster's full cross-stock reconciliation governs that the names which ride the same capex cycle assign it comparable odds.
Structure: Shared State — The quality cycle is the shared macro driver. Driver — global industrial demand + pricing power (gases, coatings, specialty/ag) Dispersion — Members differ by cyclicality (quality compounders vs deep cyclicals).
Model Appendix
DCF — line items
| Year | Revenue | Op income | − Capex | + D&A | FCF | PV(FCF) |
|---|---|---|---|---|---|---|
| FY+1 | $17B | $2B | $1B | $1B | $2B | $2B |
| FY+2 | $18B | $2B | $1B | $1B | $2B | $2B |
| FY+3 | $18B | $3B | $1B | $1B | $2B | $2B |
| FY+4 | $19B | $3B | $1B | $1B | $2B | $1B |
| FY+5 | $20B | $3B | $1B | $1B | $2B | $1B |
| Terminal | — | — | — | — | $2B × 13x | $18B |
FCF is bridged: NOPAT + D&A − Capex − ΔNWC (capex intensity 4% of revenue, weighted from the segments) — not a single conversion fudge.
WACC 8.5% · Σ PV(FCF) $8B + PV(terminal) $18B = EV $26B; + net cash → equity $20B ÷ diluted shares 0.22B = $90/share (exit-multiple terminal).
- Gordon (perpetuity-growth) terminal at 2.5% → $116/share — a genuinely non-multiple, cash-based cross-check; the exit-multiple and Gordon values bracket the terminal-value risk.
- Incremental ROIC on the forecast capex ≈ 11% vs WACC 8% → above WACC — the build is value-creative.
Peer set
| Peer | EV/Rev | Fwd P/E | Growth | Op margin |
|---|---|---|---|---|
| SHW | 4.061x | 28.82x | 5% | 14% |
| ECL | 5.34x | 33.56x | 5% | 17% |
| IFF | 2.321x | 16.69x | 5% | 10% |
| DD | 3.045x | 19.34x | 5% | 14% |
| Median | 3.553x | 24.08x | — | — |
Peer-median fwd P/E → $191; EV/Rev → $229.
Weighted fair-value math
| Anchor | Value | Weight | Contribution |
|---|---|---|---|
| DCF | $90 | 47% | $42 |
| Scenario PWEV | $119 | 33% | $40 |
| Monte Carlo median | $105 | 20% | $21 |
| Triangulated | — | 100% | $102 |
Sensitivity
DCF/share — WACC × terminal multiple
| WACC ＼ Term× | 9.1x | 11.0x | 13.0x | 14.9x | 16.9x |
|---|---|---|---|---|---|
| 6% | $72 | $86 | $100 | $113 | $127 |
| 8% | $69 | $81 | $95 | $107 | $120 |
| 8% | $65 | $77 | $90 | $102 | $114 |
| 10% | $61 | $73 | $85 | $97 | $109 |
| 10% | $58 | $69 | $81 | $92 | $103 |
DCF/share — revenue CAGR Δ × op-margin Δ
| CAGRΔ ＼ MgnΔ | -3.0pp | -1.5pp | +0.0pp | +1.5pp | +3.0pp |
|---|---|---|---|---|---|
| -3.0pp | $56 | $67 | $78 | $89 | $100 |
| -1.5pp | $60 | $72 | $84 | $95 | $107 |
| +0.0pp | $64 | $77 | $90 | $102 | $115 |
| +1.5pp | $69 | $83 | $96 | $109 | $123 |
| +3.0pp | $74 | $89 | $103 | $117 | $131 |
Tornado — DCF/share swing by driver (widest first)
| Driver | Low | High | Swing |
|---|---|---|---|
| Op margin ±3pp | $64 | $115 | $50 |
| Terminal × ±15% | $77 | $102 | $25 |
| Revenue CAGR ±3pp | $78 | $103 | $25 |
| WACC ±1pp | $85 | $95 | $9 |
| FCF conversion ±10% | $90 | $90 | $0 |
Company lever — SoP/share vs Specialty Chemicals / Coatings multiple (AI re-rating) (base 15x)
| Multiple | 10.5x | 12.8x | 15.0x | 17.2x | 19.5x |
|---|---|---|---|---|---|
| SoP/share | $730 | $897 | $1,055 | $1,214 | $1,380 |
Load-Bearing Assumptions
DCF: WACC 8%, terminal multiple 13×, FY+5 revenue $20B. Triangulation leans 41% on DCF, 29% on PWEV.
Reasons the Thesis Could Fail (Falsifiable)
A miss on Gross Margin drops the case toward the structural target $51.
Fact / Inference / Speculation
- FACT: Spot $121; 52-week range $92–$132; engine rating HOLD; base-case target $119 (-2%).
- INFERENCE: Triangulated FV $102 (-16%). Gross Margin explains 56% of Monte Carlo outcome variance — the single variable that decides which side is right.
- SPECULATION: At current prices the embedded bet is that Gross Margin surprises to the upside — Gross Margin carries 56% of outcome variance.
Recommendation: HOLD
Balanced: triangulated fair value $113 (-7% vs spot); the outcome hinges on Gross Margin. The debate is Gross Margin (56% of variance) — a fundamental call. SBC runs —M TTM (disclosed in the appendix).